Last updated on November 2017

A Phase 3, double blind, randomized study of RVT-101 versus placebo when added to existing stable donepezil treatment in subjects with mild to moderate Alzheimer’s disease; RVT-101-3001


Brief description of study

A Phase 3, double blind, randomized study of RVT-101 versus placebo when added to existing stable donepezil treatment in subjects with mild to moderate Alzheimer’s disease; RVT-101-3001

Detailed Study Description

This Study is for patients that have mild to moderate Alzheimer's disease that are on a stable therapy with donepezil.

Clinical Study Identifier: TX15401

Contact Investigators or Research Sites near you

Start Over

Bonita Waites

Parker Jewish Institute
New Hyde Park, NY USA
  Connect »